In NSCLC with PD-L1 TPS ≥50%, a high ALI score (>18) was also associated with longer OS in patients treated with ICI in monotherapy (n = 156) but not in those treated with ICI + CT (n = 38) [27]. Here, CD274 is linked to non-small cell lung carcinoma.